Public Company News

Great Southern Mining has successfully completed metallurgical test work on oxidised ores from its flagship Mon Ami project in WA that showed up to 97% recovery of the contained gold. The work has confirmed that the ores are amenable to conventional cyanide leaching and gravity recovery techniques and that low reagent uptake and coarse grinding will likely result in low operating costs.

Blina Minerals ongoing due diligence work at the Maintirano copper project in western Madagascar continues to return encouraging results with eight samples returning more than 5% copper, including a sample that registered 37.5% copper and 33ppm silver. The company will now carry out airborne surveys to help locate additional vein systems as no modern exploration methods have been used at Maintirano to date.

Sovereign Metals has outlined the high grade potential of its titanium-rich rutile mineralisation in central Malawi, this week reporting significant assays from re-sampling of historical hand-auger drill holes located in two areas 40km apart. Nearly 80% of the holes contained significant titania mineralisation, with an average weighted grade of 1.89% titanium dioxide.

Hammer Metals has received some encouraging news at its Perentie project near Mt Isa in Queensland, with its first pass RC drilling campaign returning some high grade copper results. Notable results include 1m @ 4.21% copper and 0.13g/t gold from 75m down-hole at the Paddy B prospect and 2m @ 2.36% copper and 2g/t gold from 37m down-hole at the Trackside prospect.

Altech Chemicals continues to progress its high purity alumina project with the company securing the development order for the processing plant in Johor, Malaysia. Site establishment works have now commenced and will be followed by the stage 1 construction works such as the bulk earthworks, construction of retaining walls and a maintenance workshop.

Greenland Minerals now has a formal means for the Chinese processing of its rare earth concentrates from the massive Kvanefjeld project in Greenland that contains the radioactive elements uranium and thorium. This follows its largest shareholder Shenghe Resources Holding forming the China Nuclear Hua Sheng Mining joint venture with subsidiaries of China National Nuclear Corporation.

Wireline logs at Calima Energy’s first well at the revered Montney oil and gas play in Canada have returned porosities and hydrocarbon saturations comparable to those in adjacent producing wells. Analysis of the log and core data also confirmed the presence of three zones that match those already targeted by other operators in the region. The company has also spudded the first of two horizontal wells.

MGC Pharmaceuticals has secured approval from Australia’s Therapeutic Goods Administration to start the Phase IIB clinical trial of its CogniCann medical cannabis treatment for dementia and Alzheimer’s patients. The company’s manufacturing facility in Ljubljana, Slovenia, has also secured a permit to extract and develop its own Phytocannabinoid active pharmaceutical ingredients.

Australian Potash has hit a major milestone with the manufacture of high grade sulphate of potash at its pilot processing plant in Perth that exceeded its previous expectations of product quality. The 98% purity SOP product was generated from the first raw salt products from the pilot pond network at the company’s Lake Wells SOP project, located about 180km northeast of Laverton in the Goldfields region of WA.

Terrain Minerals plans to undertake a 650m RC drilling campaign at a priority and potentially high impact gold target under transported soil cover at the Wild-Viper project tenement north of Leonora in WA. A successful drilling program will validate the company’s structural geological model and potentially unlock the multiple targets it has identified throughout the tenement.

Kalia Limited’s preliminary interpretation of new geophysical data over its Mt Tore JV tenements located on Bougainville Island in PNG has identified intrusive geological complexes and structural pathways for potential mineralisation. Imagery produced from the survey data is being used by Kalia personnel on-site for the generation of new exploration targets.

PharmAust has received new data from Canada’s BRI Biopharmaceutical Research that a specific combination of diet and excipient could double the amount of its Monepantel anti-cancer drug that can be delivered into the bloodstream of dogs. This could increase the flexibility for dosing schedules of Monepantel and potentially simplify the treatment of canine cancers.